72.11.Z - Research and experimental development on biotechnology
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
62.01.Z - Computer programming activities
62.02.Z - Computer consultancy activities
62.03.Z - Computer facilities management activities
62.09.Z - Other information technology and computer service activities
63.11.Z - Data processing, hosting and related activities
86.90.E - Other human health activities notelsewhere classified
96.04.Z - Physical well-being activities
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | -20 | -24,5 | -22,6 |
EBITDA | -20 | -24,5 | -22,5 |
Short time liabilities | 11,4 | 16,7 | 47,2 |
Equity capital | 580 | 555,4 | -4,2 |
Operating profit (EBIT) | -20 | -24,5 | -22,5 |
Assets | 591,3 | 572,1 | -3,2 |
Net profit (loss) | -20 | -24,5 | -22,6 |
Cash | 6,7 | 58,8 | 780,3 |
Net income from sale | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 11,4 | 16,7 | 47,2 |
Working assets | 85,4 | 107 | 25,3 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | -3,5 | -4,4 | -0,9 |
Equity capital to total assets | 98,1 | 97,1 | -1 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 7.527045249938965 | 6.407390117645264 | -1,1 |
Net dept to EBITDA | 0.33339694142341614 | 2.3958897590637207 | 2,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane